Marksans Pharma on Monday informed the exchanges that it has received approval from the US Food and Drug Administration for an ANDA for Loratadine liquid filled capsules 10 mg. Loratadine liquid filled capsules is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, skin rashes, itching and other symptoms of allergy. Shares of Marksans Pharma jumped 10.5 per cent at ₹52.75 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.